Global SPECT Systems Market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for diagnostic imaging systems and rising prevalence of diseases.
The global SPECT Systems Market is segmented on the basis of type, application, and region. On the basis of type, it is classified into hybrid SPECT system, standalone SPECT system, and singlphoton emission computed tomography (SPECT) system. On the basis of application, it is classified into diagnostic laboratories, research institutes and hospitals. On the basis of region it includes North America (US, Canada), Latin America (Brazil), Europe (Germany), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
-The SPECT systems market is expected to grow at a CAGR of 5.5% from 2017 to 2022.
-The growth of the SPECT systems market is driven by the increasing demand for nuclear imaging in various medical applications such as oncology, cardiology, neurology, and others.
-Increasing number of nuclear medicine centers and hospitals are also driving the growth of this market.
Industry Growth Insights published a new data on “Single-photon Emission Computed Tomography (SPECT) Systems Market”. The research report is titled “Single-photon Emission Computed Tomography (SPECT) Systems Market research by Types (Hybrid SPECT System, Standalone SPECT System, Single-photon Emission Computed Tomography (SPECT) System), By Applications (Diagnostic Laboratories, Research Institutes, Hospitals, Others), By Players/Companies GE Healthcare, Guerbet, Lantheus Medical Imaging, Daiichi Sankyo, Eli Lillyand Company, Bayer, Gamma Medica-Ideas Inc, Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, Neusoft Medical Systems, Single-photon Emission Computed Tomography (SPECT) System”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Single-photon Emission Computed Tomography (SPECT) Systems Market Research Report
By Type
Hybrid SPECT System, Standalone SPECT System, Single-photon Emission Computed Tomography (SPECT) System
By Application
Diagnostic Laboratories, Research Institutes, Hospitals, Others
By Companies
GE Healthcare, Guerbet, Lantheus Medical Imaging, Daiichi Sankyo, Eli Lillyand Company, Bayer, Gamma Medica-Ideas Inc, Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, Neusoft Medical Systems, Single-photon Emission Computed Tomography (SPECT) System
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
 Systems Industry Outlook.svg)
Global Single-photon Emission Computed Tomography (SPECT) Systems Market Report Segments:
The global Single-photon Emission Computed Tomography (SPECT) Systems market is segmented on the basis of:
Types
Hybrid SPECT System, Standalone SPECT System, Single-photon Emission Computed Tomography (SPECT) System
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Laboratories, Research Institutes, Hospitals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Guerbet
- Lantheus Medical Imaging
- Daiichi Sankyo
- Eli Lillyand Company
- Bayer
- Gamma Medica-Ideas Inc
- Siemens Healthineers
- Philips Healthcare
- Toshiba Medical Systems Corporation
- Neusoft Medical Systems
- Single-photon Emission Computed Tomography (SPECT) System
 Systems Market Overview.svg)
Highlights of The Single-photon Emission Computed Tomography (SPECT) Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hybrid SPECT System
- Standalone SPECT System
- Single-photon Emission Computed Tomography (SPECT) System
- By Application:
- Diagnostic Laboratories
- Research Institutes
- Hospitals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Single-photon Emission Computed Tomography (SPECT) Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Systems Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Single-photon emission computed tomography (SPECT) systems are a type of medical imaging that uses gamma rays to create images of the body. SPECT scans use a large number of detectors to produce detailed images of organs and tissues in the body.
Some of the major players in the single-photon emission computed tomography (spect) systems market are GE Healthcare, Guerbet, Lantheus Medical Imaging, Daiichi Sankyo, Eli Lillyand Company, Bayer, Gamma Medica-Ideas Inc, Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, Neusoft Medical Systems, Single-photon Emission Computed Tomography (SPECT) System.
The single-photon emission computed tomography (spect) systems market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Single-photon Emission Computed Tomography (SPECT) Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Single-photon Emission Computed Tomography (SPECT) Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Single-photon Emission Computed Tomography (SPECT) Systems Market - Supply Chain
4.5. Global Single-photon Emission Computed Tomography (SPECT) Systems Market Forecast
4.5.1. Single-photon Emission Computed Tomography (SPECT) Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Single-photon Emission Computed Tomography (SPECT) Systems Market Size (000 Units) and Y-o-Y Growth
4.5.3. Single-photon Emission Computed Tomography (SPECT) Systems Market Absolute $ Opportunity
5. Global Single-photon Emission Computed Tomography (SPECT) Systems Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Type
5.3.1. Hybrid SPECT System
5.3.2. Standalone SPECT System
5.3.3. Single-photon Emission Computed Tomography (SPECT) System
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Single-photon Emission Computed Tomography (SPECT) Systems Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Application
6.3.1. Diagnostic Laboratories
6.3.2. Research Institutes
6.3.3. Hospitals
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Single-photon Emission Computed Tomography (SPECT) Systems Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Single-photon Emission Computed Tomography (SPECT) Systems Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Single-photon Emission Computed Tomography (SPECT) Systems Demand Share Forecast, 2019-2026
9. North America Single-photon Emission Computed Tomography (SPECT) Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Application
9.4.1. Diagnostic Laboratories
9.4.2. Research Institutes
9.4.3. Hospitals
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Type
9.7.1. Hybrid SPECT System
9.7.2. Standalone SPECT System
9.7.3. Single-photon Emission Computed Tomography (SPECT) System
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Single-photon Emission Computed Tomography (SPECT) Systems Demand Share Forecast, 2019-2026
10. Latin America Single-photon Emission Computed Tomography (SPECT) Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Application
10.4.1. Diagnostic Laboratories
10.4.2. Research Institutes
10.4.3. Hospitals
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Type
10.7.1. Hybrid SPECT System
10.7.2. Standalone SPECT System
10.7.3. Single-photon Emission Computed Tomography (SPECT) System
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Single-photon Emission Computed Tomography (SPECT) Systems Demand Share Forecast, 2019-2026
11. Europe Single-photon Emission Computed Tomography (SPECT) Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Application
11.4.1. Diagnostic Laboratories
11.4.2. Research Institutes
11.4.3. Hospitals
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Type
11.7.1. Hybrid SPECT System
11.7.2. Standalone SPECT System
11.7.3. Single-photon Emission Computed Tomography (SPECT) System
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Single-photon Emission Computed Tomography (SPECT) Systems Demand Share, 2019-2026
12. Asia Pacific Single-photon Emission Computed Tomography (SPECT) Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Application
12.4.1. Diagnostic Laboratories
12.4.2. Research Institutes
12.4.3. Hospitals
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Type
12.7.1. Hybrid SPECT System
12.7.2. Standalone SPECT System
12.7.3. Single-photon Emission Computed Tomography (SPECT) System
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Single-photon Emission Computed Tomography (SPECT) Systems Demand Share, 2019-2026
13. Middle East & Africa Single-photon Emission Computed Tomography (SPECT) Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Application
13.4.1. Diagnostic Laboratories
13.4.2. Research Institutes
13.4.3. Hospitals
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Single-photon Emission Computed Tomography (SPECT) Systems Market Size and Volume Forecast by Type
13.7.1. Hybrid SPECT System
13.7.2. Standalone SPECT System
13.7.3. Single-photon Emission Computed Tomography (SPECT) System
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Single-photon Emission Computed Tomography (SPECT) Systems Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Single-photon Emission Computed Tomography (SPECT) Systems Market: Market Share Analysis
14.2. Single-photon Emission Computed Tomography (SPECT) Systems Distributors and Customers
14.3. Single-photon Emission Computed Tomography (SPECT) Systems Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GE Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Guerbet
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Lantheus Medical Imaging
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Daiichi Sankyo
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eli Lillyand Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bayer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Gamma Medica-Ideas Inc
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Siemens Healthineers
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Philips Healthcare
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Toshiba Medical Systems Corporation
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Neusoft Medical Systems
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Single-photon Emission Computed Tomography (SPECT) System
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY
